These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 22771394
1. How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease? Kleopa KA, Abrams CK, Scherer SS. Brain Res; 2012 Dec 03; 1487():198-205. PubMed ID: 22771394 [Abstract] [Full Text] [Related]
2. X-linked Charcot-Marie-Tooth disease. Scherer SS, Kleopa KA. J Peripher Nerv Syst; 2012 Dec 03; 17 Suppl 3(0 3):9-13. PubMed ID: 23279425 [Abstract] [Full Text] [Related]
3. Molecular genetics of X-linked Charcot-Marie-Tooth disease. Kleopa KA, Scherer SS. Neuromolecular Med; 2006 Dec 03; 8(1-2):107-22. PubMed ID: 16775370 [Abstract] [Full Text] [Related]
4. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. Scherer SS, Xu YT, Messing A, Willecke K, Fischbeck KH, Jeng LJ. J Neurosci; 2005 Feb 09; 25(6):1550-9. PubMed ID: 15703409 [Abstract] [Full Text] [Related]
5. Intrathecal gene therapy in mouse models expressing CMT1X mutations. Kagiava A, Karaiskos C, Richter J, Tryfonos C, Lapathitis G, Sargiannidou I, Christodoulou C, Kleopa KA. Hum Mol Genet; 2018 Apr 15; 27(8):1460-1473. PubMed ID: 29462293 [Abstract] [Full Text] [Related]
6. Connexins, gap junctions and peripheral neuropathy. Kleopa KA, Sargiannidou I. Neurosci Lett; 2015 Jun 02; 596():27-32. PubMed ID: 25449862 [Abstract] [Full Text] [Related]
9. Two new mouse models of Gjb1-associated Charcot-Marie-Tooth disease type 1X. Tadenev ALD, Hatton CL, Pattavina B, Mullins T, Schneider R, Bogdanik LP, Burgess RW. J Peripher Nerv Syst; 2023 Sep 02; 28(3):317-328. PubMed ID: 37551045 [Abstract] [Full Text] [Related]
10. Gene expression profiling studies in regenerating nerves in a mouse model for CMT1X: uninjured Cx32-knockout peripheral nerves display expression profile of injured wild type nerves. Freidin M, Asche-Godin S, Abrams CK. Exp Neurol; 2015 Jan 02; 263():339-49. PubMed ID: 25447941 [Abstract] [Full Text] [Related]
11. Golgi-retained Cx32 mutants interfere with gene addition therapy for CMT1X. Kyriakoudi S, Sargiannidou I, Kagiava A, Olympiou M, Kleopa KA. Hum Mol Genet; 2017 May 01; 26(9):1622-1633. PubMed ID: 28334782 [Abstract] [Full Text] [Related]
12. Gap junction disorders of myelinating cells. Kleopa KA, Orthmann-Murphy J, Sargiannidou I. Rev Neurosci; 2010 May 01; 21(5):397-419. PubMed ID: 21280457 [Abstract] [Full Text] [Related]
18. Prenylation-defective human connexin32 mutants are normally localized and function equivalently to wild-type connexin32 in myelinating Schwann cells. Huang Y, Sirkowski EE, Stickney JT, Scherer SS. J Neurosci; 2005 Aug 03; 25(31):7111-20. PubMed ID: 16079393 [Abstract] [Full Text] [Related]
19. Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects. Sargiannidou I, Vavlitou N, Aristodemou S, Hadjisavvas A, Kyriacou K, Scherer SS, Kleopa KA. J Neurosci; 2009 Apr 15; 29(15):4736-49. PubMed ID: 19369543 [Abstract] [Full Text] [Related]